- Home
- CGEN vs AGCC Comparison
CGEN vs AGCC Comparison
Compare CGEN & AGCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGEN | AGCC |
|---|---|---|
| Founded | 1993 | 2020 |
| Country | Israel | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.2M | 209.9M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGEN | AGCC |
|---|---|---|
| Price | $2.20 | $15.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 216.3K | ★ 253.7K |
| Earning Date | 05-18-2026 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $112.37 | N/A |
| P/E Ratio | ★ N/A | $168.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.13 | $4.23 |
| 52 Week High | $2.38 | $24.98 |
Technical Indicators
Market Signals| Indicator | CGEN | AGCC |
|---|---|---|
| Relative Strength Index (RSI) | 57.76 | 51.09 |
| Support Level | $1.47 | $13.47 |
| Resistance Level | $2.35 | $18.11 |
| Average True Range (ATR) | 0.10 | 1.54 |
| MACD | -0.00 | -0.20 |
| Stochastic Oscillator | 61.35 | 23.77 |
Price Performance
Historical ComparisonAbout CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
About AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares
Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.